IE
DMAC icon

Israel Englander’s DiaMedica Therapeutics DMAC Stock Holding History

Israel Englander’s Portfolio DMAC Stock Details DMAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.95M Sell
845,309
-90,283
-10% -$555K ﹤0.01% 2823
2026
Q1 		$6.33M Buy
935,592
+167,032
+22% +$1.32M ﹤0.01% 2678
2025
Q4 		$6.12M Sell
768,560
-418,749
-35% -$3.13M ﹤0.01% 2788
2025
Q3 		$8.16M Buy
+1,187,309
New +$6.44M ﹤0.01% 2598
2025
Q2 		– Sell
-336,880
Closed -$1.28M – 5946
2025
Q1 		$1.28M Buy
336,880
+252,051
+297% +$1.44M ﹤0.01% 4164
2024
Q4 		$461K Buy
84,829
+51,139
+152% +$241K ﹤0.01% 4815
2024
Q3 		$141K Buy
+33,690
New +$124K ﹤0.01% 5525
2024
Q1 		– Sell
-28,845
Closed -$81.9K – 6253
2023
Q4 		$81.9K Buy
28,845
+173
+0.6% +$428 ﹤0.01% 5387
2023
Q3 		$74K Buy
+28,672
New +$92.1K ﹤0.01% 5408
2022
Q1 		– Sell
-22,249
Closed -$83K – 7012
2021
Q4 		$83K Buy
+22,249
New +$87.4K ﹤0.01% 6325
2021
Q3 		– Sell
-20,690
Closed -$92K – 6865
2021
Q2 		$92K Sell
20,690
-49,591
-71% -$407K ﹤0.01% 6250
2021
Q1 		$643K Buy
70,281
+29,420
+72% +$275K ﹤0.01% 4612
2020
Q4 		$414K Buy
+40,861
New +$224K ﹤0.01% 4345
2020
Q2 		– Sell
-10,872
Closed -$30K – 4236
2020
Q1 		$30K Sell
10,872
-22,091
-67% -$91.3K ﹤0.01% 3711
2019
Q4 		$160K Sell
32,963
-37,956
-54% -$118K ﹤0.01% 3926
2019
Q3 		$145K Sell
70,919
-28,421
-29% -$91.9K ﹤0.01% 3881
2019
Q2 		$493K Buy
+99,340
New +$344K ﹤0.01% 3245

Other funds holding DMAC

CLG
Cooperman Leon G $3.55B AUM 41.85% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Israel Englander's DMAC Position: Q2 2026 in Review

Israel Englander reduced its DiaMedica Therapeutics (DMAC) stake by 9.6% in Q2 2026, selling an estimated $555K and leaving 845,309 shares worth $5.95M. The position accounts for ﹤0.01% of the portfolio, ranked #2823.

Israel Englander first reported a position in DMAC in Q2 2019 and has held it in 17 quarters since. The position peaked at $8.16M in Q3 2025. 88 funds tracked by Wall St. Rank hold DMAC as of Q2 2026.

  • Israel Englander held 845,309 shares of DiaMedica Therapeutics worth $5.95M as of Q2 2026.
  • Israel Englander sold 90,283 DiaMedica Therapeutics shares in Q2 2026, an estimated $555K.
  • DiaMedica Therapeutics made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #2823 holding.
  • Israel Englander first reported a position in DiaMedica Therapeutics in Q2 2019 and has held it in 17 quarters since.
  • Israel Englander's DiaMedica Therapeutics position peaked at $8.16M in Q3 2025.
  • 88 funds tracked by Wall St. Rank held DiaMedica Therapeutics as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.